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Available online 8 April 2016Purpose: Hyperkyphosis, accentuated curvature of the thoracic spine, is often attributed to osteoporosis, yet its
underlying pathophysiology is not well understood. Bone turnover markers (BTM) reﬂect the dynamic process
of bone formation and resorption. This study examined the association between serum BTM levels and kyphosis
in community-dwelling older adults.
Methods: Between 2003 and 2006, 760 men and women in the Rancho Bernardo Study age 60 and older had
blood drawn and kyphosis measured. Fasting serum was assayed for N-telopeptide (NTX) and procollagen
type 1 n-terminal propeptide (P1NP), markers of bone resorption and formation, respectively. Participants re-
quiring two ormore 1.7 cm blocks under their head to achieve a neutral supine positionwere classiﬁed as having
accentuated kyphosis. Analyses were stratiﬁed by sex and use of estrogen therapy (ET). Odds of accentuated ky-
phosis were calculated for each standard deviation increase in log-transformed BTM.
Results:Mean agewas 75 years. Overall, 51%of 341 non-ET usingwomen, 41% of 111 ET-usingwomen, and 75% of
308 men had accentuated kyphosis. In adjusted models, higher P1NP and NTX were associated with decreased
odds of accentuated kyphosis in non-ET using women (P1NP: OR = 0.78 [95% CI, 0.58–0.92]; NTX: OR = 0.68
[95% CI, 0.54–0.86]), but not in men or ET-using women (p N 0.05).
Conclusions: The selective association of higher bone turnoverwith reduced odds of accentuated kyphosis in non-
ET using women suggests that elevated BTM were associated with a lower likelihood of hyperkyphosis only in
the low estrogen/high BTM environment characteristic of postmenopausal women who are not using ET.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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NTX1. Introduction
Bone remodeling or turnover is the dynamic process of bone forma-
tion and resorption that is carried out by osteoblasts and osteoclasts
throughout the life span (Marieb, 2001). Previous studies have shown
associations between elevated or unbalanced turnover, as indicated by
various bone turnovermarkers (BTM), and bone disorders such as oste-
oporosis and fracture (Cauley et al., 2012; Garnero, 2009; Tamaki et al.,
2013). For example, a prospective study of 522 postmenopausalwomen
reported that higher BTM were associated with an increased risk oftelopeptide; P1NP, procollagen
Study of Osteoporotic Fractures.
avidson).
. This is an open access article undervertebral fracture amongwomenwhowere at leastﬁve years pastmen-
opause (Tamaki et al., 2013).
There are at least 15 different recognized biomarkers of bone turn-
over (Wheater et al., 2013), reﬂective of the bone metabolic processes
formation and resorption. Althoughusually these processes are coupled,
such that bone formation and bone resorption markers demonstrate
parallel dynamics, a complete clinical picture is best obtained by mea-
surement of both a resorption and a formation marker. A suitable
bone formation marker for measurement in serum is P1NP, a cleavage
product of Type 1 pro-collagen. There is low intra-individual variability
of P1NP and a wide dynamic range in relation to clinical conditions.
NTX, a cleavage product of Type 1 collagen, is an appropriate biomarker
of bone resorption marker that is stable in serum; commercial assays
provide measurements with the required precision.
Hyperkyphosis, accentuated curvature of the thoracic spine, has
been estimated to affect up to 40% of community-dwelling older adultsthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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pulmonary function, increased falls and fractures, and mortality (Kado
et al., 2003, 2004, 2007; Ryan and Fried, 1997). However, little is
known about the mechanisms leading to hyperkyphosis. To date,
there are no standard treatments available for people with accentuated
kyphosis. Better understanding of the underlying pathophysiology of
hyperkyphosis may help elucidate which types of interventions might
be most promising to help individuals with hyperkyphosis.
To our knowledge, no studies have reported the association between
bone turnovermarkers (BTM) and kyphosis. The purpose of this study is
to examine the associations of accentuated kyphosis with serum colla-
gen type 1 cross-linked N-telopeptide (NTX), a marker of bone resorp-
tion, and procollagen type 1 N-terminal propeptide (P1NP), a marker
of bone formation, in a large sample of community-dwelling older
men and women unselected for osteoporosis or kyphosis.
2. Materials and methods
2.1. Participants
Between 1972 and 1974, 6629 adult residents from Rancho
Bernardo, a largely white, middle class community in southern Califor-
nia were enrolled in a cohort study of healthy aging. Between August
2003 and January 2006, 870 surviving, ambulatory participants
attended a clinic visit designed to study osteoporosis and other age-
related disorders. The study sample included 760 participants (308
men and 452 women) who remained after excluding 58 participants
who were then younger than age 60, 39 missing measures of kyphosis,
11without stored serum for BTM assessment, and two lacking informa-
tion on estrogen therapy (ET).
The University of California, San Diego Human Research Protections
Program approved this research protocol; all participants gave written
informed consent prior to participation.
2.2. Procedures
During the 2003–2006 research clinic visit, morning fasting blood
samples were obtained by venipuncture by a clinic nurse and frozen
for later analysis. Kyphotic status was assessed by a trained radiology
technician by placing 1.7 cm blocks under each participant's head. The
number of blocks required to achieve a neutral position while lying su-
pine on a ﬂat surfacewas recorded; the greater the number of blocks re-
quired to achieve a neutral position, the more accentuated the angle of
kyphosis. Details of this method of measuring kyphosis have been pre-
viously described (Kado et al., 2004).
Height andweight were alsomeasured by a nurse using a calibrated
stadiometer and balance beam scale with participants wearing light
clothing and without shoes. Maximum waist girth was measured as
an estimate of central obesity; body mass index (BMI; kg/m2) was cal-
culated as an estimate of overall obesity.
Total hip bone mineral density (BMD; g/cm2) was measured using
dual x-ray absorptiometry on a DXA Hologic 1000 (Waltham, MA),
which was calibrated daily using a phantom with a precision error of
1.5% or less.
A self-administered survey was used to obtain information on
smoking history (never/ever), alcohol intake (drinks per week), exer-
cise ≥3 times per week (no/yes), education and history of physician-
diagnosed comorbidities (stroke, diabetes, emphysema, chronic bron-
chitis, arthritis, Parkinson's disease, and spine fracture). Information
on current medication and supplement use, including ET in women,
was obtained by a nurse who validated with medication containers
and prescriptions brought to the clinic for that purpose.
In 2008, serum NTX (BCE/l) was measured at SPD Development
Company Limited (Bedford, UK) using the Osteomark ELISA (Unipath
Ltd, UK); serum P1NP (μg/L) was measured by (UniQ, OrionDiagnostica) at Orion Diagnostica Oy (Oulu, Finland). Intra- and
interassay coefﬁcients of variation ranged from 2–6%.
Education level was categorized into high school or less, some col-
lege, a college degree or more. Alcohol intake was dichotomized into
heavy drinking (yes/no) using sex-speciﬁc criteria; men consuming 21
or more drinks per week (three or more drinks per day) and women
consuming 14 or more drinks per week (two or more drinks per day)
were considered heavy drinkers based on the USDA deﬁnition of mod-
erate drinking as up to one drink per day for women and up to two
drinks per day for men (U.S. Department of Agriculture and U.S.
Department of Health and Human Services, 2010).
2.3. Statistical analysis
All analyses were sex-speciﬁc due to differences between men and
women in weight, height, and BMD; analyses of womenwere stratiﬁed
by ET use due to the known effect of exogenous estrogen on bone turn-
over. Bivariate analyses to detect differences in covariates between
those with normal versus accentuated kyphotic status were performed
using age-adjusted logistic regression. Covariates with age adjusted
p b 0.25 were included in saturated multivariate logistic regression
models to examine the association between P1NP and NTX with ky-
photic status (normal/accentuated) in each stratum. Covariates not sig-
niﬁcant at α= 0.05 were removed from the saturated model. These
variables were then placed back into the model one-by-one to assess
for possible inclusion and/or confounding. Confoundingwas considered
present if the effect size of themarker changed by amagnitude of 0.5 or
more. Effect modiﬁcation by use of osteoporosis medications was
assessed by including an interaction term in the ﬁnalmodel. Odds ratios
from these logistic regressionmodels represent the odds of accentuated
kyphosis for each standard deviation increase in continuous variables.
Normal kyphotic status was deﬁned as the use of 0 or 1 block to
achieve a neutral supine position; those requiring 2 or more blocks
were deﬁned as having accentuated kyphotic status. This cut point
was determined based on observed differences in physical function dur-
ing exploratory analysis. NTX and P1NP levels were not normally dis-
tributed and were log transformed for all analyses; reported values
are geometric means.
Statistical analyses were conducted using SPSS (version 19.0, SPSS
Inc., Chicago, IL) and SAS (version 9.2, SAS Institute, Cary, NC). Statistical
signiﬁcance was deﬁned as two-sided p b 0.05 for all tests.
3. Results
Mean age of the study samplewas 75 years (range=60–100). Prev-
alence of accentuated kyphotic status differed signiﬁcantly between the
three study groups (χ2 = 55.813, p b 0.001) but did not differ signiﬁ-
cantly between the non-ET using and ET-using women (χ2 = 3.610,
p = 0.057); 51% of 341 non-ET using women, 41% of 111 ET-using
women, and 75% of 308 men had accentuated kyphosis. Levels of both
bone turnover biomarkers also differed signiﬁcantly across the three
study groups (ANOVA p b 0.001 for NTX and P1NP); NTX and P1NP
levels were highest in non-ET using women (geometric means
[GM] = 1.154 and 1.590, interquartile ranges [IQR] = 1.050–1.256
and 1.442–1.744), intermediate in men (GM = 1.113 and 1.521,
IQR = 1.015–1.208 and 1.397–1.648), and lowest in ET using women
(GM= 1.080 and 1.448, IQR = 0.993–1.146 and 1.280–1.603).
Age-adjusted comparisons of characteristics for each group by ky-
photic status are shown in Table 1. NTX and P1NP were signiﬁcantly
lower in non-ET using women with accentuated kyphosis compared
with their non-kyphotic counterparts, but did not differ by kyphotic sta-
tus in men or ET using women. Men with accentuated kyphosis were
signiﬁcantly younger and weighed more than those with normal ky-
photic status, but did not differ by mean height, BMI, total hip BMD,
use of medications, or any behavioral or lifestyle characteristics. Non-
ET using women with accentuated kyphosis weighed more, had higher
Table 1
Comparisons of characteristics by kyphotic status in men and women aged 60 and older; Rancho Bernardo, CA (2003–2006).
Men
(n = 308)
Non-ET using women
(n = 341)
ET using women
(n = 111)
0–1 block
(n = 77)
2+ blocks
(n = 231)
pa 0–1 block
(n = 167)
2+ blocks
(n = 174)
pa 0–1 block
(n = 65)
2+ blocks
(n = 46)
pa
Characteristic, M (SD)
NTX, BCE/lb 13.5 (1.4) 12.9 (1.4) 0.507 15.1 (1.4) 13.5 (1.4) 0.003 12.3 (1.5) 11.8 (1.4) 0.510
P1NP, μg/Lb 35.5 (1.6) 32.4 (1.6) 0.095 41.7 (1.6) 36.3 (1.7) 0.026 28.2 (1.8) 27.5 (1.6) 0.982
Age, years 77.4 (9.9) 73.5 (6.6) b0.001 75.6 (9.3) 75.9 (8.0) 0.749 72.4 (9.3) 75.0 (8.0) 0.120
Height, in 67.9 (2.9) 68.9 (2.5) 0.108 63.0 (2.3) 62.9 (2.5) 0.922 63.3 (2.3) 63.2 (2.1) 0.635
Weight, lb 171.7 (24.9) 184.1 (28.3) 0.024 138.1 (22.6) 146.7 (28.5) 0.002 140.4 (26.3) 155.1 (32.7) 0.004
BMI, kg/m2 26.1 (2.9) 27.2 (3.7) 0.083 24.5 (3.9) 26.0 (4.9) 0.001 24.6 (4.4) 27.1 (4.7) 0.004
Waist girth, cm 96.3 (9.0) 99.0 (14.6) 0.144 81.1 (10.1) 86.2 (16.8) 0.001 80.6 (10.8) 89.5 (23.7) 0.013
Total hip BMD, mg/cm2 0.92 (0.14) 0.95 (0.14) 0.308 0.78 (0.13) 0.78 (0.14) 0.937 0.87 (0.12) 0.89 (0.12) 0.246
Characteristic, % yes
Education level 0.664 0.479 0.693
≤HS diploma 15 12 31 36 26 24
Some college 30 24 41 35 38 47
≥College degree 55 64 28 29 36 29
Osteoporosis med use 4 6 0.504 25 34 0.062 9 15 0.454
CA2+ supplement use 39 29 0.108 64 54 0.077 71 54 0.097
Vit D supplement use 30 24 0.245 45 43 0.673 54 46 0.479
Ever smoked 53 61 0.188 40 52 0.021 42 50 0.308
Heavy alcohol intakec 3 7 0.298 8 14 0.081 6 11 0.405
Exercise ≥3 times/week 77 81 0.583 73 62 0.038 75 59 0.091
History of comorbiditiesd 35 39 0.237 34 43 0.093 35 35 0.825
a p-Value is age adjusted.
b Values are log-transformed.
c Heavy alcohol intake deﬁned as 21 drinks or more per week for men and 14 drinks or more per week for women.
d Self-reported history of stroke, diabetes, emphysema, chronic bronchitis, arthritis, Parkinson's disease, and/or clinical spinal fracture.
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less likely to exercise three or more times per week. ET using women
with accentuated kyphosis weighed more, had higher BMI and waist
girth, but did not differ in any behavioral or lifestyle characteristics
from those with normal kyphotic status.
Table 2 shows the association of BTMwith kyphotic status inwomen
by ET use. Among non-ET using women, higher P1NP and NTX were
each independently associated with 22 to 32% lower odds of accentuat-
ed kyphosis in age-adjusted and fully adjusted models. Additional
sequential adjustment for osteoporosis medication use and calcium
supplement use did not materially alter the results (data not shown).
Among ET using women, no signiﬁcant associations were found be-
tween BTM and kyphotic status. Higher BMI was independentlyTable 2
Associations of bone turnover markers with accentuated kyphosis; results of multivariate logis
Marker type Model Variable Non-
OR
Bone formation P1NP – age adjusted
Log P1NP, μg/L (SD) 0.78
Age, years (SD) 0.99
P1NP – fully adjusted
Log P1NP, μg/L (SD) 0.73
Age, years (SD) 1.04
BMI, kg/m2 (SD) 1.53
Ever smoked, yes 1.75
Bone resorption NTX – age adjusted
Log NTX, BCE/l (SD) 0.71
Age, years (SD) 1.07
NTX – fully adjusted
Log NTX, BCE/l (SD) 0.68
Age, years (SD) 1.13
BMI, kg/m2 (SD) 1.51
Ever smoked, yes 1.76
a The dependent variable reference category is normal kyphotic status (0–1 blocks).associated with increased odds of accentuated kyphosis in women, re-
gardless of ET use.
Table 3 shows the association of bone formation and resorption
markers with kyphotic status in men. Neither NTX nor P1NP were
associated with kyphotic status in men in either the age-adjusted or
fully adjustedmodels. Lower age and higherweightwere each indepen-
dently associated with increased odds of accentuated kyphosis in men.
4. Discussion
Because hyperkyphosis in older persons is associated with several
adverse outcomes and has no standard clinical treatment, it is important
to investigate potential mechanisms for this disorder that might providetic regressiona models in women aged 60 and older; Rancho Bernardo, CA (2003–2006).
ET users ET users
95% CI p-Value OR 95% CI p-Value
n = 341 n = 111
0.62–0.97 0.026 1.00 0.68–1.45 0.982
0.80–1.24 0.957 1.35 0.92–1.98 0.121
n = 340 n = 111
0.58–0.92 0.007 0.92 0.62–1.37 0.688
0.83–1.30 0.758 1.46 0.98–2.19 0.065
1.22–1.94 b0.001 1.88 1.23–2.86 0.003
1.12–2.72 0.014
n = 341 n = 111
0.57–0.89 0.003 0.88 0.59–1.30 0.510
0.86–1.33 0.530 1.36 0.93–1.99 0.114
n = 340 n = 111
0.54–0.86 0.001 0.83 0.55–1.26 0.377
0.90–1.42 0.290 1.48 0.99–2.21 0.059
1.19–1.90 b0.001 1.89 1.24–2.88 0.003
1.12–2.75 0.013
Table 3
Associations of bone turnover markers with accentuated kyphosis; results of multivariate
logistic regressionmodelsa inmen aged 60 and older; Rancho Bernardo, CA (2003–2006;
n = 308).
Marker type Model Variable OR 95% CI p-Value
Bone formation P1NP – age
adjusted
Log P1NP, μg/L (SD) 0.79 0.61–1.04 0.095
Age, years (SD) 0.60 0.46–0.78 b0.001
P1NP – fully
adjusted
Log P1NP, μg/L (SD) 0.78 0.59–1.02 0.071
Age, years (SD) 0.67 0.51–0.89 0.006
Weight, lbs (SD) 1.46 1.07–2.01 0.018
Bone resorption NTX – age
adjusted
Log NTX, BCE/l (SD) 0.91 0.70–1.19 0.507
Age, years (SD) 0.61 0.47–0.80 b0.001
NTX – fully
adjusted
Log NTX, BCE/l (SD) 0.93 0.71–1.22 0.600
Age, years (SD) 0.68 0.52–0.91 0.009
Weight, lbs (SD) 1.43 1.04–1.95 0.026
a The dependent variable reference category is normal kyphotic status (0–1 blocks).
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report of the association between BTM and kyphosis. We found that in-
creased serum levels ofmarkers of bone formation (P1NP) and resorption
(NTX) were each independently associated with reduced odds of kypho-
sis in non-ET using women, and that serum levels of BTM were signiﬁ-
cantly higher in these women than in ET-using women or men. BTM
were not associated with kyphotic status in men or ET using women.
Highbone turnover is associatedwith osteoporosis (Manolagas, 2000)
and fracture (Cauley et al., 2012; Tamaki et al., 2013), where bone loss re-
sults from increased activity and longer lifespan of osteoclasts coupled
with osteoblast activity that is unable to compensate for the elevated re-
sorption (Weitzmann and Paciﬁci, 2006). Results of the present study
suggest that high bone turnover characterized by increased osteoclast
and osteoblast activity may provide protection against the development
of hyperkyphosis in non-ET using women. Wolff's law states that me-
chanical stress is able to trigger bone remodeling in humans (Marieb,
2001). Bennell (Bennell et al., 1997) observed elevated resorption
markers in female power athletes and postulated that the “pattern of
bone strain…could trigger local growth factors…which alter the remodel-
ing process.” It is conceivable that in some persons, age-related biome-
chanical forces that cause adverse loading conditions on the vertebral
body (Ebbesen et al., 1999) could trigger a compensatory biological re-
sponse with elevated bone turnover, reﬂecting active remodeling in at-
tempts to avoid development of wedge compression deformities. This
may be particularly evident in non-ET using women who have much
lower levels of circulating estradiol than ET-using women and older
men, who have comparable circulating estradiol levels. Interestingly, we
have also recently reported that oldermenwith lower endogenous estra-
diol levels have increased kyphosis, suggesting that hypoestrogenemia
plays an important role in the development of hyperkyphosis (Kado
et al., 2013a). Future research should address the inﬂuence of endogenous
estradiol on bone turnover and kyphosis in both sexes.
Among the three study groups, ET using women had the lowest
serum BTM as well as the lowest prevalence of accentuated kyphosis.
It is possible that kyphosis is suppressed by ET use. Research in the
Study of Osteoporotic Fractures has linked estrogen use with less ky-
phosis progression (Woods et al., 2014). This result has biological plau-
sibility since bone turnover is known to be suppressed by ET use.
In this study of individuals aged 60 and older, relatively younger age
in men was associated with higher odds of accentuated kyphosis that
was likely due to survivor bias in the cohort. In our 2004 report (Kado
et al., 2004), hyperkyphotic men from a previous clinic visit in the Ran-
cho Bernardo Study had a signiﬁcantly higher ﬁve-year mortality rate
than non-kyphotic men. Thus, the current study population did not in-
clude those from the previous study who died and who also had the
most extreme kyphotic posture. As both older age and kyphosis are as-
sociated with increased mortality rates, it is plausible that the majority
of the oldest men in the present study were those who were the least
affected by hyperkyphosis as compared with men in the younger agegroup who had the advantage of overall lower mortality rates. Why
this protective association of greater age is not observed among the
women in the present study is unclear.
Additionally, obesity (greater weight in men and higher BMI and
weight in women) was associated with increased odds of accentuated
kyphosis. These results are in agreement with our earlier study (Kado
et al., 2013b) showing that greaterweightwas associatedwithmore ky-
phosis in a cohort of 1000 women from the Study of Osteoporotic Frac-
tures (SOF). The greater load that accompanies greater weight may
adversely change posture, particularly in older adults who typically
have less muscle mass for a given weight than younger persons (Lang
et al., 2010).
In the present study, history of smoking was associated with a 75%
increase in the odds of accentuated kyphosis among non-ET users.
These ﬁndings contrast with those of our earlier study (Kado et al.,
2013b), which found that current smokingwas associated with less ky-
phosis amongwomen in SOF. However, 80% of the participants selected
for the SOF kyphosis study had to have serial x-rays completed over a
15-year period of follow-up and survivor biasmay explain the disparate
ﬁndings.
This study has some limitations. Due to its cross-sectional nature,
these results can be considered only suggestive, describing associations
rather than causation. The blocksmethodmay lack sensitivity and spec-
iﬁcity, although inter-rater reliability was 0.85 at the Rancho Bernardo
clinic. Nonetheless, this study might have beneﬁtted from a more pre-
cise measure of thoracic kyphosis, such as the Cobb angle, which was
not calculated for most participants at this visit. The study might also
have beneﬁtted from additional clinicalmeasures such as fracture histo-
ry in relation to the measurement of bone turnover markers, radio-
graphic presence of degenerative disc disease and vertebral fractures
as well as further information about type of estrogen use. Lastly, the
generalizability of our results is limited to non-Hispanic white, ambula-
tory, community-dwelling older adults.
This study also has several strengths. Sample sizes of the men and
non-ET using women were relatively large. Information was collected
on awide range of covariates that could have altered BTM, kyphotic sta-
tus, or both. Additionally, bone turnover markers were assayed using
state of the art methods performed in experienced laboratories.
Results of this study suggest that elevated BTM are associated with a
lower likelihood of hyperkyphosis only in the low estrogen/high BTM en-
vironment that is characteristic of postmenopausal women who are not
using ET. These ﬁndings should be validated in other cohorts. The effect
of estrogen on the mechanisms leading to kyphosis warrant further re-
search so that interventions can be developed to treat or prevent
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